Related Experiment Video
Updated: Jul 3, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
When to use drugs to help sleep
1Evelina Children's Hospital, St Thomas' Hospital, London, UK. Paul.gringras@gstt.nhs.uk
Insights
Paediatric sleep medicine is a growing field addressing childhood sleep disorders. While behavioral therapies are key, evidence for pharmacological treatments is limited, necessitating more research and trials.
Area of Science:
- Pediatric Sleep Medicine
- Childhood Sleep Disorders
Background:
- Paediatric sleep medicine is an emerging, critical field.
- Many adult sleep disorders originate in childhood, with severe consequences if undiagnosed.
- Accurate diagnosis relies on healthcare professional training and symptom assessment.
Purpose of the Study:
- To highlight the current state and future directions of paediatric sleep medicine.
- To emphasize the need for improved diagnostic and treatment strategies for childhood sleep disorders.
Main Methods:
- Review of current practices and evidence in paediatric sleep medicine.
- Analysis of the limitations in pharmacological treatment evidence for childhood sleep conditions.
- Identification of the need for increased randomized controlled trials (RCTs) and international collaboration.
Main Results:
- Behavioral approaches are central, but severe cases may require pharmacotherapy.
- The evidence base for pharmacological treatments in children is currently weak.
- There is an encouraging increase in RCTs and improving trial methodologies.
Conclusions:
- Further research, including international multicenter trials, is essential.
- Evaluating new technologies and pharmacological treatments requires robust evidence.
- Addressing the growing field of paediatric sleep medicine is crucial for child health.
Abstract:
Paediatric sleep medicine is a relatively new but important and rapidly growing field. It is increasingly recognised that many "adult" sleep disorders begin in childhood where the consequences of missed diagnoses can be devastating. Adequate training of all health care professionals and careful eliciting of symptoms remains the first step in ensuring accurate and timely diagnoses. Although behavioural approaches play a huge role in paediatric sleep medicine, at times severe sleep disorders also require pharmacological treatments. However, the evidence base for these is weak, and currently treatments of conditions including insomnia, narcolepsy and restless legs syndrome in childhood still rely on hopeful extrapolation from adult data. A growth in randomised controlled trials over the last 5 years is encouraging; trial methodologies are also improving. International working groups and multicentre trials will increasingly be needed to evaluate the new technologies and pharmacological treatments that are emerging.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...

